Warren Buffett says American banking companies could experience extra turbulence ahead, but deposits are harmless

Vital Points

Berkshire Hathaway CEO Warren Buffett on Saturday assailed regulators, politicians and the media for perplexing the public about the basic safety of U.S. financial institutions and said that ailments could worsen.
Buffett, when requested about the modern tumult that led to the collapse of 3 mid-sized institutions because March, released into a lengthy diatribe about the situation.
“We want to be there if the banking procedure briefly will get stalled in some way,” he claimed. “It should not, I don’t assume it will, but it could.”

Supply

Finance

JPMorgan Chase reins in lending to private credit firms after marking down software loans

March 11, 2026

Key Points JPMorgan is marking down collateral held by private credit firms and reducing their borrowing capacity — a preemptive move driven by market valuations, not actual loan losses. The markdowns target software company loans, where AI advances have sparked fears of disintermediation, triggering a private credit downcycle and abnormally high redemptions at firms like […]

Finance

Stocks making the biggest moves premarket: Oracle, AeroVironment, Nike and more

March 11, 2026

Check out the companies making headlines before the bell. Oracle — Oracle shares jumped more than 9% after the cloud infrastructure company gave strong fiscal third quarter results and lifted its revenue guidance for fiscal 2027. Management lifted its fiscal 2027 revenue outlook up $1 billion to $90 billion. Analysts polled by LSEG sought $86.6 […]

Finance

Stocks making the biggest moves midday: Rivian, Hims & Hers, BioNTech, Vertex Pharmaceuticals & more

March 10, 2026

Check out some of the companies making the biggest moves midday: Hims & Hers Health — Shares of the telehealth company jumped 3%. Bank of America upgraded the stock to neutral from underperform after Novo Nordisk dropped its patent infringement case against Hims, and the companies agreed that Hims would sell Novo’s Ozempic and Wegovy […]